BOSTON--(BUSINESS WIRE)--Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, today announced a $220M Series D round co-led by Altimeter Capital and Coatue, joined ...

The COVID-19 pandemic emphasized the need for quicker clinical trial enrollment and more decentralized studies to assuage safety concerns. Those long-lasting impacts have given investors the ...

Reify Health says $220 million in new funding will support development of its diversity-focused clinical trial recruitment technologies and initiatives. The Boston-based software developer completed ...

Clinical trial tech company Reify Health raised $220 million in Series D funding, boosting the company's valuation to $4.8 billion. The round was led by Altimeter Capital and Coatue with participation ...

As the Covid-19 pandemic led more companies to turn to decentralized clinical trials, investors are pouring funding into a software firm that is looking to streamline these processes. Reify Health ...

As funding levels for the biopharma sector ratchet up without interruption, investors are increasingly betting on companies that are using technology to improve the efficiency and pace at which ...

A company that markets cloud computing systems for the biopharma industry has raised $30 million in a Series B funding round. Boston-based Reify Health said Wednesday that it had closed the round, led ...

We've lost the physicality of music and music culture Allison Wood, CEO Reify Music is never just "digital": from instruments to headphones and digital devices, even a world of streaming audio is a ...

Clinical trial solutions company announces new, multi-year initiative addressing one of the most pressing challenges in life sciences BOSTON--(BUSINESS WIRE)--Reify Health, a leading provider of ...